Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

RxSpan MD vs Curex

Two GLP-1 desks, one scoreboard. We put RxSpan MD and Curex head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 85 · Grade C

RxSpan MD

Visit RxSpan MD Full brief →
vs
Higher Brief ScoreNo. 21 · Grade B

Curex

Visit Curex Full brief →

FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.

The verdict

Curex takes this head-to-head.

Curex scores 86 to 72 on our six-factor Brief Score — Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.

That doesn't make RxSpan MD a bad call — it's best for readers who want to check who is prescribing and who is compounding before they buy, and who will change the pre-selected plan back to monthly unless they actually mean to pay a year up front. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
66
85
Supply Reliability
82
85
Transparency
56
87
Access Breadth
88
90
Clinical Oversight
78
86
Track Record
62
81
RxSpan MDBrief Score 72 · 86Curex

Price, coverage & the tracker

RxSpan MDCurex
Brief Score72/100 (C)86/100 (B)
Semaglutide$249/mo month-to-month, compounded — the funnel pre-selects a 3-month prepay at $657 up front, and its cheapest rung is $2,327 for a year in one charge$199/mo
Tirzepatide$329/mo month-to-month, compounded — 3 months bills $927 up front, 12 months $3,228$199/mo
CoverageAll 50 states claimed — asynchronous review is not available in all of themAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingStableprice stable

RxSpan MD: First reading of the live catalog, 8 August 2026, replacing a dataset line that had never been checked against it. Month-to-month is $249 semaglutide and $329 tirzepatide; the ladder runs down to $194 and $269 a month, but only by paying $2,327 or $3,228 in a single charge. The cheapest GLP-1 figures RxSpan publishes anywhere — $179 and $199, in its own product API — are on no storefront page and buy nothing.

Curex: Flat $199 on both molecules; LegitScript-certified and nationwide.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.